Ru Liu

发表

Comparison of Percutaneous Coronary Intervention, Coronary Artery Bypass Grafting and Medical Therapy in Non-ST Elevation Acute Coronary Syndrome Patients With 3-Vessel Disease.

R. Hui, K. Sun, Jing-jing Xu, 2020, Circulation journal : official journal of the Japanese Circulation Society.

Association of PEAR1 genetic variants with platelet reactivity in response to dual antiplatelet therapy with aspirin and clopidogrel in the Chinese patient population after percutaneous coronary intervention.

Jingjing Xu, Jing-jing Xu, B. Xu, 2016, Thrombosis research.

Predictors and consequences of postdischarge gastrointestinal bleeding after percutaneous coronary intervention

Jing-jing Xu, B. Xu, Jin-qing Yuan, 2018, Cardiovascular therapeutics.

Predictive value of in-hospital white blood cell count in Chinese patients with triple-vessel coronary disease

R. Hui, Wei Zhao, K. Sun, 2019, European journal of preventive cardiology.

Association of thrombocytopenia with in-hospital outcome in patients with acute ST-segment elevated myocardial infarction

Jingang Yang, S. Qiao, Jin-qing Yuan, 2018, Platelets.

Head to Head Comparison of Two Point-of-care Platelet Function Tests Used for Assessment of On-clopidogrel Platelet Reactivity in Chinese Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention

Jing-jing Xu, Jin-qing Yuan, Lei Song, 2016, Chinese medical journal.

Relationship Between High-Sensitivity C-Reactive Protein and Long-Term Outcomes in Elderly Patients With 3-Vessel Disease

R. Hui, K. Sun, Jing-jing Xu, 2021, Angiology.

Association of Baseline Smoking Status with Long-Term Prognosis in Patients Who Underwent Percutaneous Coronary Intervention: Large Single-Center Data

Jing-jing Xu, B. Xu, S. Qiao, 2019, Journal of interventional cardiology.

Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study

Jing-jing Xu, B. Xu, S. Qiao, 2018, Cardiovascular Diabetology.

Impact of anemia on percutaneous coronary intervention in Chinese patients: A large single center data

Jingjing Xu, Jing-jing Xu, B. Xu, 2018, Journal of interventional cardiology.

Prognostic Value of Fibrinogen in Patients With Coronary Artery Disease and Prediabetes or Diabetes Following Percutaneous Coronary Intervention: Five-year Findings From a Large Cohort Study

B. Xu, Jin-qing Yuan, Yuejin Yang, 2021 .

Long-term effects of baseline on-treatment platelet reactivity in patients with acute coronary syndrome and thrombocytopenia undergoing percutaneous coronary intervention

Xiaofang Tang, Ce Zhang, R. Gao, 2022, The Journal of international medical research.

Effect of Baseline Thrombocytopenia on Long-Term Outcomes in Patients With Acute ST-Segment Elevated Myocardial Infarction　- A Large Propensity Score-Matching Analysis From the China Acute Myocardial Infarction (CAMI) Registry.

Jingang Yang, Jin-qing Yuan, Yuejin Yang, 2021, Circulation journal : official journal of the Japanese Circulation Society.

Effect of sex difference in clinical presentation (stable coronary artery disease vs unstable angina pectoris or non‐ST‐elevation myocardial infarction vs ST‐elevation myocardial infarction) on 2‐year outcomes in patients undergoing percutaneous coronary intervention

Jing-jing Xu, B. Xu, S. Qiao, 2018, Journal of interventional cardiology.

Long-term outcomes of extending dual antiplatelet therapy after drug-eluting stent implantation for acute coronary syndrome: a large single-center study

Jingjing Xu, Jing-jing Xu, B. Xu, 2019, Platelets.

Comparison between imported versus domestic drug‐eluting stents in China: A large single‐center data

B. Xu, S. Qiao, Jin-qing Yuan, 2017, Journal of interventional cardiology.

Comparison of Long-term Outcomes in Patients with Premature Triple-vessel Coronary Disease Undergoing Three Different Treatment Strategies: A Prospective Cohort Study

Jingjing Xu, K. Sun, Yanyan Zhao, 2018, Chinese medical journal.

Interaction Between Treatment and Age or Sex in Non-ST-Segment Elevation Acute Coronary Disease and Three-Vessel Disease

R. Hui, K. Sun, Jing-jing Xu, 2022, Frontiers in Cardiovascular Medicine.

Effect of NPC1L1 and HMGCR Genetic Variants With Premature Triple-Vessel Coronary Disease

R. Hui, Wei Zhao, K. Sun, 2020, Frontiers in Cardiovascular Medicine.

Platelet reactivity in patients with chronic kidney disease undergoing percutaneous coronary intervention

Jing-jing Xu, B. Xu, Jin-qing Yuan, 2018, Platelets.

Direct Bilirubin Levels Predict Long-Term Outcomes in Patients With Acute Coronary Syndrome Under Different Glucose Metabolism Status: A 6.5-Year Cohort Study of Three-Vessel Disease

Jing-jing Xu, B. Xu, Jin-qing Yuan, 2021, Frontiers in Cardiovascular Medicine.

Novel polymorphism of the HMGCR gene related to the risk of diabetes in premature triple‐vessel disease patients

R. Hui, Jing-jing Xu, Keyong Huang, 2022, The journal of gene medicine.

Does Baseline On-treatment Platelet Reactivity Impact Long-term Prognosis in Patients with Acute Coronary Syndrome and Thrombocytopenia Who Underwent Percutaneous Coronary Intervention?

B. Xu, Xiaofang Tang, Ce Zhang, 2021 .

Comparison of Efficacy and Safety between First- and Second-Generation Drug-Eluting Stents in Patients with Acute Coronary Syndrome

Jing-jing Xu, B. Xu, S. Qiao, 2018, Chinese medical journal.

Impact of Lipoprotein(a) on Long-Term (Mean 6.2 Years) Outcomes in Patients With Three-Vessel Coronary Artery Disease.

R. Hui, Jingjing Xu, K. Sun, 2019, The American journal of cardiology.

Lipoprotein(a), high-sensitivity C-reactive protein, and cardiovascular risk in patients undergoing percutaneous coronary intervention.

Zhan Gao, Jing-jing Xu, Xiaofang Tang, 2022, Atherosclerosis.

Usefulness of FT3 to FT4 Ratio to Predict Mortality in Euthyroid Patients With Prior Cardiovascular Events Undergoing PCI: Five-Year Findings From a Large Single-Center Cohort Study

Jingjing Xu, Zhan Gao, Jing-jing Xu, 2021, Frontiers in Endocrinology.

Risk or Beneficial Factors Associated with Unplanned Revascularization Risk Following Percutaneous Coronary Intervention: A Large Single-Center Data.

S. Qiao, Jin-qing Yuan, Yuejin Yang, 2020, Biomedical and environmental sciences : BES.

Five-year outcomes of biodegradable versus second-generation durable polymer drug-eluting stents used in complex percutaneous coronary intervention

Zhan Gao, Jing-jing Xu, Yaling Han, 2023, Chinese medical journal.

Comparison of Efficacy and Safety between First and Second Generation Drug-eluting Stents in Patients with Stable Coronary Artery Disease: A Single-center Retrospective Study

S. Qiao, Jin-qing Yuan, Yuejin Yang, 2017, Chinese medical journal.

Susceptible gene polymorphism in patients with three-vessel coronary artery disease

Jing-jing Xu, Jin-qing Yuan, Xiaofang Tang, 2020, BMC Cardiovascular Disorders.

Plasma big endothelin-1 and stent thrombosis: An observational study in patients undergoing percutaneous coronary intervention in China.

Jing-jing Xu, S. Qiao, Jin-qing Yuan, 2017, Thrombosis research.

Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study

Zhan Gao, Jing-jing Xu, Jin-qing Yuan, 2021, Cardiovascular Diabetology.

Stress hyperglycemia ratio and long-term prognosis in patients with acute coronary syndrome: A multicenter, nationwide study.

Jing-jing Xu, Yaling Han, Xiaozeng Wang, 2023, Journal of diabetes.

Prevalence and Prognostic Significance of Malnutrition in Patients with Abnormal Glycemic Status and Coronary Artery Disease: A Multicenter Cohort Study in China

Jing-jing Xu, Yaling Han, Xiaozeng Wang, 2023, Nutrients.

Association of CDKN2B-AS1 Polymorphisms with Premature Triple-vessel Coronary Disease and Their Sex Specificity in the Chinese Population.

K. Sun, Jing-jing Xu, Jin-qing Yuan, 2018, Biomedical and environmental sciences : BES.

For patients with prior coronary artery bypass grafting and recurrent myocardial ischemia, percutaneous coronary intervention on bypass graft or native coronary artery?—A 5‐year follow‐up cohort study

T. Yang, Xiaofang Tang, Hai-bo Liu, 2023, Clinical cardiology.

Implications of left atrial volume index in patients with three-vessel coronary disease: A 6.6-year follow-up cohort study.

R. Hui, Wei Zhao, Ce Zhang, 2023, Chinese medical journal.

Real-world long-term outcomes based on three therapeutic strategies in very old patients with three-vessel disease

R. Hui, Jing-jing Xu, Jin-qing Yuan, 2021, BMC Cardiovascular Disorders.

Prevalence and Prognostic Signiﬁcance of Malnutrition in Patients with Abnormal Glycemic Status and Coronary Artery Disease: A Multicenter Cohort Study in China

B. Horne, Jing-jing Xu, Yaling Han, 2022 .

HMGCR gene polymorphism is associated with residual cholesterol risk in premature triple-vessel disease patients treated with moderate-intensity statins

R. Hui, K. Sun, Jing-jing Xu, 2023, BMC Cardiovascular Disorders.

Association of NCP1L1 and HMGCR Gene Polymorphisms with Major Adverse Cardiac and Cerebrovascular Events in Patients with Three-Vessel Disease.

R. Hui, K. Sun, Jing-jing Xu, 2020, Human gene therapy.

Inverse Association of Lipoprotein(a) on Long-Term Bleeding Risk in Patients with Coronary Heart Disease: Insight from a Multicenter Cohort in Asia

Jing-jing Xu, Yaling Han, Xiaozeng Wang, 2022, Thrombosis and Haemostasis.

Prognostic significance of inflammation in patients with coronary artery disease at low residual inflammatory risk

Jing-jing Xu, Xiaofang Tang, Yi Yao, 2023, iScience.

Inflammation and Insulin Resistance in Diabetic Chronic Coronary Syndrome Patients

Jing-jing Xu, Yaling Han, Xiaozeng Wang, 2023, Nutrients.

Renal function alters the association of lipoprotein(a) with cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a prospective cohort study

Jing-jing Xu, Xiaofang Tang, Ce Zhang, 2024, Clinical kidney journal.

Mild Renal Function Impairment and Long-Term Outcomes in Patients with Three-Vessel Coronary Artery Disease: A Cohort Study

Jing-jing Xu, Dong Wang, Lin Jiang, 2023, Cardiorenal Medicine.